top of page
Search Results

323 items found for "Dopamine receptor D3"

  • Classified News | Dr. GPCR Ecosystem

    GPCR field Sign Up Latest Classified GPCR News Adhesion GPCRs September 25, 2024 The G Protein-Coupled Receptor promotes pressure overload-induced heart failure Read More September 5, 2024 The G protein-coupled receptor mechanism for G protein-coupled receptors, illustrated by dopamine D2-like and β2 adrenergic receptors receptor 5 (CXCR5) Read More November 1, 2024 State transitions of coupled Gi-protein: Insights into internal water channel dynamics within dopamine receptor D3 from in silico submolecular analyses Read

  • Dopamine-Mediated Motor Recovery after Ischemic Stroke

    About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Dopamine-Mediated Marc Caron, where I cloned the dopamine D5 receptor gene and investigated the regulation of dopaminergic and adrenergic receptors. My addiction for dopamine led me to the Ottawa Hospital Research Institute (then the Moses and Rose Loeb (DA) receptors.

  • A journey from Duke to McGill along the dopamine circuit

    Committee Sponsors GPCR Retreat Program < Back to schedule A journey from Duke to McGill along the dopamine the INSERM Laboratory directed by Jean-Charles Schwartz in Paris, where he cloned and characterized dopamine D2 and D3 receptor subtypes. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

  • Interrogating Multiscale Receptors Functions in Space

    establishing a role for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors (D2R) functions. These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors, thus providing a framework to understand how different drug classes can engage overlapping

  • Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease

    Salahpour worked on Dopamine Transporter and its role on regulating dopamine transmission and homeostasis the Department of Pharmacology and Toxicology at University of Toronto and has continued working on dopamine transmission and homeostasis and the role of several of key modulators of the dopamine system, including the dopamine transporter (DAT), the Vesicular Monoamine Transporter 2 (VMAT2), Tyrosine Hydroxylase (TH) and Trace Amine Associate Receptor 1 (TAAR1)."

  • Trainee Symposium I

    During his graduate studies, Emile is interested in characterizing novel G protein-coupled receptors GPCR Title: Synapse-Associated Protein 102 and Post-Synaptic Density 95 Differentially Shape Dopamine D1 Receptor Signaling About Bassam Albraidy "My thesis focus on studying the interaction of dopamine D1 receptors scaffolding proteins synapse-associated protein 102 and post-synaptic density 95, and the du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

  • Atypical Structure and Function of Typical Chemokine Receptors

    Sponsors GPCR Retreat Program < Back to schedule Atypical Structure and Function of Typical Chemokine Receptors of the principal efforts of our laboratory is to understand the physiological consequences of NMDA receptor The NMDA receptor is a subtype of glutamate neurotransmitter receptor that regulates the formation and Our laboratory is interested in the role of NMDA receptors not only on neurons, but also on other cells Our laboratory has a long-standing interest in the way that NMDA receptors contribute to the symptoms

  • Ep 150 with Dr GPCR Team

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the Latrophilin 3 receptor. free energy landscape analysis to understand the signaling pathways and activation mechanisms of the Dopamine D3 receptor and the CXCR4-CXCL12 complex.

  • Chemoattractant receptor signaling in humoral immunity

    < GPCR News < GPCRs in Oncology and Immunology Chemoattractant receptor signaling in humoral immunity on orchestrated migration of B cells within lymphoid organs, which is governed by G protein-coupled receptors ligand binding, GPCRs are phosphorylated by different GPCR kinases (GRKs) at distinct sites on the receptor C termini, which dictates functional outcomes of β-arrestin-mediated signaling, ranging from receptor In this review, we summarize the current understanding of chemoattractant receptor signaling in the context

  • Ep 71 with Dr. Jean Martin Beaulieu

    establishing a role for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors (D2R) functions. These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors, thus providing a framework to understand how different drug classes can engage overlapping

  • Regulation and role of mitochondria delta opioid receptors

    Committee Sponsors GPCR Retreat Program < Back to schedule Regulation and role of mitochondria delta opioid receptors pharmacology and has published seminal papers where he used various approaches to describe the role of opioid receptors anagesia as well as to study the mechanisms involved in the cellular trafficking of the delta opioid receptor GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

  • The Effect of Cancer-Associated Mutations on Ligand Binding and Receptor Function - A Case for the 5-HT2C Receptor

    < GPCRs in Oncology and Immunology The Effect of Cancer-Associated Mutations on Ligand Binding and Receptor Function - A Case for the 5-HT2C Receptor Published date October 29, 2024 Abstract "The serotonin 5- HT2C receptor is a G protein-coupled receptor (GPCR) mainly expressed in the central nervous system. In this study, we aimed to investigate the effects of cancer patient-derived 5-HT2C receptor mutations on ligand binding and receptor functionality.

  • Ep 114 with Dr. Robert F. Bruns

    retired at the end of 2014 and since then has been writing papers on his final major project at Lilly, a dopamine doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

  • GPCR Retreat Schedule 2023

    Dinner 1 Read More Friday, November 3rd / 7:30 AM Breakfast 1 Read More Friday, November 3rd / 8:30 AM Dopamine-Mediated Research Institute Read More Friday, November 3rd / 8:55 AM A journey from Duke to McGill along the dopamine Read More Friday, November 3rd / 9:45 AM Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Break 3 Read More Friday, November 3rd / 10:40 AM Regulation and role of mitochondria delta opioid receptors Brazil Read More Friday, November 3rd / 1:55 PM A positive Allosteric Modulator of M1 Acetylcholine Receptors

  • Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)

    Immunology Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR) Published date August 29, 2024 Abstract "The growth hormone-releasing hormone receptor (GHRHR ) belongs to Class B1 of G protein-coupled receptors (GPCRs). of the receptor and, subsequently, the N-terminus interacts with the seven transmembrane domain of the receptor, resulting in activation.

  • Ep 87 with Dr. Bianca Plouffe

    same university in 2005 by investigating the molecular mechanisms involved in the angiotensin type 2 receptor She identified the molecular mechanisms involved in the opposite regulation of dopamine D1 and D5 receptors She identified the structural determinant controlling biased signaling of melatonin type 2 receptors Award, she investigated biased and compartmentalized G protein signaling by the vasopressin type 2 receptor understanding the role of compartmentalized Gq signaling by the cytomegalovirus-encoded chemokine US28 receptor

  • Ep 37 with Dr. Samuel Hoare

    Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors life science, and academic scientists in the development of new therapeutics and the understanding of receptor about his love for GPCRs, kinetics, and decorticate the complexities of GPCR function to better target receptors

  • Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy

    < GPCR News < GPCRs in Oncology and Immunology Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy Published date October 4, 2024 Abstract "Olfactory receptors (ORs) are a class of G protein-coupled receptors (GPCR) widely distributed in olfactory sensory neurons and various Increasing evidence reveals the heightened expression of olfactory receptors in tumorous tissues and Authors Yi Tang, Ye Tian, Chun-Xia Zhang, Guo-Tai Wang Tags G Protein-coupled receptors , Olfactory receptors

  • G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells

    < GPCR News < GPCRs in Oncology and Immunology G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein 30 (GPR30), also named G protein-coupled estrogen receptor (GPER), and the β1-adrenergic receptor (β1AR ) are G protein-coupled receptors (GPCR) that are implicated in breast cancer progression. , Björn Olde , Kathleen M Caron , L M Fredrik Leeb-Lundberg Tags Breast cancer , GPER , GPR30 , PDZ domain

  • Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer

    < GPCR News < GPCRs in Oncology and Immunology Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer Published date June ) receptor inhibited the growth of GAL2 receptor-expressing patient-derived xenografts (PDX) of pancreatic with high GAL2 receptor expression. for GAL2 receptor agonists.

  • From odor to oncology: non-canonical odorant receptors in cancer

    < GPCR News < GPCRs in Oncology and Immunology From odor to oncology: non-canonical odorant receptors in cancer Published date December 12, 2023 Abstract "Odorant receptors, traditionally associated with Alongside the canonical GPCR odorant receptors, dysregulation of non-canonical odorant receptors such as trace amine-associated receptors (TAARs), formyl peptide receptors (FPRs), and membrane-spanning The roles of these non-canonical chemoreceptors in cancer are complex, with some receptors promoting

  • Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors

    in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors Published date December 1, 2022 Abstract G Protein-coupled receptors (GPCRs) are the most frequently While the location of the mutations across the protein domains did not differ significantly in the two Our approach was confirmed by re-discovery of established cancer targets such as the LPA and mGlu receptor families, but also discovered novel GPCRs which had not been linked to cancer before such as the P2Y Receptor

  • Signaling by Neutrophil G Protein-Coupled Receptors that Regulate the Release of Superoxide Anions

    < GPCR News < GPCRs in Oncology and Immunology Signaling by Neutrophil G Protein-Coupled Receptors that Neutrophils, which express many receptors that are members of the large family of G protein-coupled receptors (FPRs) and free fatty acids recognized by free fatty acid receptors (FFARs) regulate neutrophil functions The activation profiles of these receptors include the release of reactive oxygen species (ROS) generated The receptors have signaling and functional similarities, although there are also important differences

  • Complex Allosteric Cannabinoid Receptor Pharmacology

    Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec

  • Ep 106 with Dr. Bruno Giros

    the INSERM Laboratory directed by Jean-Charles Schwartz in Paris, where he cloned and characterized dopamine D2 and D3 receptor subtypes.

  • Interplay between G protein-coupled receptors and nanotechnology

    < GPCR News < GPCRs in Oncology and Immunology Interplay between G protein-coupled receptors and nanotechnology Published date July 28, 2023 Abstract "G protein-coupled receptors (GPCRs), as the largest family of membrane receptors, actively modulate plasma membrane and endosomal signalling. , GPCR ligands can endow nanoparticles with active targeting capacity for specific cells via ligand-receptor binding and mediate receptor-dependent endocytosis of nanoparticles.

  • C5aR2 receptor: The genomic twin of the flamboyant C5aR1

    < GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that Authors Aurosikha Das, Pulkit K Gupta, Soumendra Rana Tags C5a; C5aR2/C5L2 receptor; lipid bilayer; molecular

  • G protein coupled receptor transcripts in human immune cells and platelets

    < GPCR News < GPCRs in Oncology and Immunology G protein coupled receptor transcripts in human immune cells and platelets Published date September 27, 2024 Abstract "G-protein coupled receptors (GPCRs) On average, the white cells studied expressed 160 receptor mRNAs (range, 123-206). Some, but far from all, of the receptors we found have been detected earlier. We believe our data should stimulate studies of receptor function and contribute to drug development.

bottom of page